SUMMARY Two children with lupus erythematosus and myelopathy were studied. The first child developed the neonatal lupus erythematosus syndrome associated with transplacentally acquired anti-Ro/SSA antibodies. The cutaneous manifestations of neonatal lupus erythematosus disappeared but a residual myelopathy was confirmed at 16 months of age. The second child developed cutaneous lupus erythematosus at 3 months of age associated with a total deficiency of the Clr component of complement. A myelopathy and mesangial glomerulonephritis developed at 2 years of age which required treatment with corticosteroids. These two children with CNS lupus erythematosus, one associated with transplacentally acquired antibodies and the other associated with a complement deficiency, may suggest an immune-mediated mechanism for the pathogenesis of myelopathy in childhood lupus erythematosus.
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Neonatal lupus erythematosus is a rare disorder which consists of skin lesions, primarily facial, occurring at birth or shortly thereafter. 16 The disease has been associated with congenital heart block and the presence of passively acquired maternal anti-Ro/SSA and occasionally anti-La/SSB antibodies.'6 Systemic symptoms do not usually develop in these children during the neonatal period6 although several children have subsequently developed systemic lupus erythematosus in the second decade of life. 24 manifestations and heart block. Immu-sient symptoms but, as observed in our first case, noglobulin and complement depositions were noted these antibodies may also be associated with peron the atrial appendage of a three day old infant with manent neurological sequelae. The pathogenesis for this syndrome and suggested a causal relationship the neurological damage in neonatal lupus erybetween the passively transferred antibodies and car-thematosus may be similar to the proposed immune diac symptoms.24 Ro(SSA) antigen has been found in mediated mechanisms causing congenital heart block. fetal and adult cardiac tissues and anti-Ro/(SSA) In addition, the myelopathy of infantile lupus eryantibody binding in serum was noted to be decreased thematosus associated with a complement deficiency in a child with congenital heart block compared to an may suggest a similar autoimmune basis for the neuunaffected twin.25 Anti-Ro antibodies were also rological disorder. Lupus erythematosus should be found in mothers of infants with isolated congenital considered in the differential diagnosis of early onset heart block.26Antibodies to 
